"von Willebrand Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.
| Descriptor ID |
D014842
|
| MeSH Number(s) |
C15.378.100.100.900 C15.378.100.141.900 C15.378.140.900 C15.378.463.920 C16.320.099.920
|
| Concept/Terms |
von Willebrand Diseases- von Willebrand Diseases
- Hemophilia, Vascular
- Vascular Hemophilia
- Vascular Hemophilias
- Vascular Pseudohemophilia
- Pseudohemophilia, Vascular
- Pseudohemophilias, Vascular
- Vascular Pseudohemophilias
- Von Willebrand's Factor Deficiency
- Von Willebrand Disorder
- Disorder, Von Willebrand
- von Willebrand's Disease
- von Willebrand's Diseases
- Angiohemophilia
- Angiohemophilias
- von Willebrand Disease
|
Below are MeSH descriptors whose meaning is more general than "von Willebrand Diseases".
Below are MeSH descriptors whose meaning is more specific than "von Willebrand Diseases".
This graph shows the total number of publications written about "von Willebrand Diseases" by people in this website by year, and whether "von Willebrand Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 1 | 2 |
| 1996 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "von Willebrand Diseases" by people in Profiles.
-
Rodenticidal hepatotoxicity: Raised plasma Von Willebrand factor levels predict in-hospital survival and preliminary report of the outcome of Von Willebrand factor reducing management protocol. Indian J Gastroenterol. 2019 12; 38(6):527-533.
-
Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center. Thromb Haemost. 2000 Jul; 84(1):93-7.
-
Practice guidelines and treatment of patients with von Willebrand's disease. Anesthesiology. 1996 Aug; 85(2):441-2.
-
The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity. Ann Clin Lab Sci. 1995 Jul-Aug; 25(4):306-9.
-
A rapid method for the diagnosis of von Willebrand's disease subtypes by the clinical laboratory. Arch Pathol Lab Med. 1995 Feb; 119(2):148-52.
-
Acquired von Willebrand's disease following bone marrow transplantation. Ann Clin Lab Sci. 1994 May-Jun; 24(3):211-5.
-
Management of a patient with type IIC von Willebrand's disease during coronary artery bypass graft surgery. Anesthesiology. 1993 Jan; 78(1):195-7.
-
Acquired von Willebrand's syndrome associated with an extranodal pulmonary lymphoma. Arch Pathol Lab Med. 1988 Jan; 112(1):47-50.
-
Use of a bleeding time determination in the evaluation of unexplained hematuria. J Urol. 1987 Mar; 137(3):527-8.
-
Acquired von Willebrand syndrome due to an inhibitor specific for von Willebrand factor antigens. Am J Hematol. 1986 Mar; 21(3):305-14.